ArticleDiscover oncology2025

Integrated bioinformatics and functional studies identify CDK9 as a potential prognostic biomarker and therapeutic target in AML.

Zhibin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.